IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-39595-y.html
   My bibliography  Save this article

Herpes zoster vaccine safety in the Aotearoa New Zealand population: a self-controlled case series study

Author

Listed:
  • James F. Mbinta

    (Victoria University of Wellington)

  • Alex X. Wang

    (Victoria University of Wellington)

  • Binh P. Nguyen

    (Victoria University of Wellington)

  • Janine Paynter

    (University of Auckland)

  • Prosper Mandela A. Awuni

    (Laurentian University)

  • Russell Pine

    (Victoria University of Wellington)

  • Andrew A. Sporle

    (Faculty of Science, University of Auckland)

  • Steve Bowe

    (Victoria University of Wellington)

  • Colin R. Simpson

    (Victoria University of Wellington
    The University of Edinburgh)

Abstract

In Aotearoa New Zealand, zoster vaccine live is used for the prevention of zoster and associated complications in adults. This study assessed the risk of pre-specified serious adverse events following zoster vaccine live immunisation among adults in routine clinical practice. We conducted a self-controlled case series study using routinely collected national data. We compared the incidence of serious adverse events during the at-risk period with the control period. Rate ratios were estimated using Conditional Poisson regression models. Falsification outcomes analyses were used to evaluate biases in our study population. From April 2018 to July 2021, 278,375 received the vaccine. The rate ratio of serious adverse events following immunisation was 0·43 (95% confidence interval [CI]: 0·37–0·50). There was no significant increase in the risk of cerebrovascular accidents, acute myocardial infarction, acute pericarditis, acute myocarditis, and Ramsay–Hunt Syndrome. The herpes zoster vaccine is safe in adults in Aotearoa New Zealand.

Suggested Citation

  • James F. Mbinta & Alex X. Wang & Binh P. Nguyen & Janine Paynter & Prosper Mandela A. Awuni & Russell Pine & Andrew A. Sporle & Steve Bowe & Colin R. Simpson, 2023. "Herpes zoster vaccine safety in the Aotearoa New Zealand population: a self-controlled case series study," Nature Communications, Nature, vol. 14(1), pages 1-9, December.
    • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-39595-y
    DOI: 10.1038/s41467-023-39595-y
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-39595-y
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-023-39595-y?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Colin R. Simpson & Steven Kerr & Srinivasa Vittal Katikireddi & Colin McCowan & Lewis D. Ritchie & Jiafeng Pan & Sarah J. Stock & Igor Rudan & Ruby S. M. Tsang & Simon Lusignan & F. D. Richard Hobbs &, 2022. "Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland," Nature Communications, Nature, vol. 13(1), pages 1-7, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Vahé Nafilyan & Charlotte R. Bermingham & Isobel L. Ward & Jasper Morgan & Francesco Zaccardi & Kamlesh Khunti & Julie Stanborough & Amitava Banerjee & James C. Doidge, 2023. "Risk of death following COVID-19 vaccination or positive SARS-CoV-2 test in young people in England," Nature Communications, Nature, vol. 14(1), pages 1-11, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-39595-y. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.